For Maryland, the signs of a rising life sciences concentration were already there before the pandemic.

Long home to federal institutions like the National Institutes of Health and leading universities, suburban areas like Montgomery County have long been home to a cluster of talent and companies working to commercialize pharmaceuticals, biotech and medical devices. Then came the pandemic. The federal government needed to invest in new treatments to stop the spread of COVID-19. In Maryland, the companies around the NIH and FDA figured prominently in the solution, as many had expertise that left them poised to jump into the fight.

In its 2020 outlook for the industry nationally, published in the summer of 2020, commercial real estate services company JLL ranked Maryland fourth, behind only Boston, San Francisco and San Diego.

READ FULL ARTICLE HERE